Biomerica (BMRA) Short term Debt (2011 - 2012)
Biomerica (BMRA) posted Short term Debt of $43000.0 for Q2 2012, up 266.21% sequentially from $11742.0 in Q4 2011, and up 21.5% YoY from $35390.0 in Q2 2011.
Biomerica (BMRA) Short term Debt (2011 - 2012) Analysis & Trends
Biomerica has reported Short term Debt for 2 years, with the latest figure at $43000.0 in Q2 2012.
- Quarterly Short term Debt rose 21.5% year-over-year to $43000.0 in Q2 2012, while the trailing twelve-month figure through May 2012 was $43000.0 (up 21.5% YoY) and the FY2012 annual result came in at $43000.0, up 21.5% from the prior year.
- Short term Debt climbed to $43000.0 in Q2 2012 per BMRA's latest filing, from $11742.0 in the prior quarter.
- Over five years, Short term Debt peaked at $43000.0 in Q2 2012 and troughed at $11742.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.38 Bn | 196.77 Bn | 7.27 Bn |
| 2 | Stryker | 126.28 Bn | 122.80 Bn | 4.50 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.10 Bn | 73.56 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.67 Bn | 47.42 Bn | 1.35 Bn |
| 6 | Dexcom | 35.07 Bn | 33.12 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.20 Bn | 22.88 Bn | 4.55 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn |
| 10 | Biomerica | 4.91 Mn | 3.57 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2012 | 43,000.00 |
| Nov 30, 2011 | 11,742.00 |
| Aug 31, 2011 | 23,664.00 |
| May 31, 2011 | 35,390.00 |